Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma. Oncotarget (2015) 0.83

From Benchtop to Bedside: A Review of Oncolytic Virotherapy. Biomedicines (2016) 0.78

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma. Oncotarget (2016) 0.77

Mouse models of liver cancer: Progress and recommendations. Oncotarget (2015) 0.77

Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma. Oncotarget (2016) 0.75

Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment. Sci Rep (2017) 0.75

The HSP70 family and cancer. Carcinogenesis (2013) 2.06

Patient-derived xenografts for individualized care in advanced sarcoma. Cancer (2014) 1.82

One mouse, one patient paradigm: New avatars of personalized cancer therapy. Cancer Lett (2013) 1.49

Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol (2009) 1.44

Trial watch: Oncolytic viruses for cancer therapy. Oncoimmunology (2013) 1.36

Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics. Neoplasia (2013) 1.17

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer. Oncotarget (2014) 1.06

Stress for maintaining memory: HSP70 as a mobile messenger for innate and adaptive immunity. Eur J Immunol (2010) 1.06

Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS One (2012) 1.02

Heat shock proteins, autoimmunity, and cancer treatment. Autoimmune Dis (2012) 0.98

Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer. Mol Oncol (2011) 0.96

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy. Oncotarget (2014) 0.94

An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma. Mol Oncol (2012) 0.93

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer (2013) 0.92

CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. Cancer Lett (2012) 0.91

Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. J Surg Res (2013) 0.91

Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus. Cancer Gene Ther (2013) 0.87

MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells. Virol J (2013) 0.87

DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen. Hum Gene Ther (2005) 0.86

Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor. Cancer Lett (2013) 0.83

Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin (2005) 0.81